cilastatin has been researched along with clindamycin in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (37.50) | 18.7374 |
| 1990's | 9 (37.50) | 18.2507 |
| 2000's | 5 (20.83) | 29.6817 |
| 2010's | 1 (4.17) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Ibayashi, H; Ishii, H; Kuramoto, H; Kuroda, Y; Nakayama, Y; Tanaka, A | 1 |
| Canteras, M; Gómez, J; Martín-Luengo, F; Ros, J; Ruiz, J; Valdés, M | 1 |
| Buchmann, P; Christen, D; Geroulanos, S; Stern, A | 1 |
| Busuttil, RW; Christou, NV; Dellinger, EP; Solomkin, JS | 1 |
| Kager, L; Malmborg, AS; Nord, CE | 1 |
| Eriksson, M; Norrby, SR; Ottosson, E | 1 |
| Creger, RJ; Danziger, LH; Hau, T; Shwed, JA; Stellato, TA | 1 |
| Barza, M; Gorbach, SL; Hackford, AW; Reinhold, RB; Tally, FP | 1 |
| Buchmann, P; Christen, D; Geroulanos, S | 1 |
| Appleman, MD; Berne, TV; Chenella, FC; Gill, MA; Heseltine, PN; Leedom, JM; Yellin, AE | 1 |
| Gorbach, SL; Tally, FP | 1 |
| Alexander, JW; Fant, WK; Rivera, JO; Solomkin, JS | 1 |
| Cakmakci, M; Christen, D; Geroulanos, S; Roggo, A; Schilling, J; Stern, A | 1 |
| de Groot, HG; Hustinx, PA; Lampe, AS; Oosterwijk, WM | 1 |
| Hirai, H; Hotta, Y; Kitagawa, S; Machi, T; Matsuda, Y; Miyamori, H; Nakamura, S; Nakamura, Y; Saito, Y; Taguchi, T; Yamatani, H | 1 |
| Faulkner, K; Wilson, SE | 1 |
| de Lissovoy, G; Elixhauser, A; Luce, BR; Mowery, P; Reblando, J; Solomkin, J; Weschler, J | 1 |
| Biesenbach, G; Schinko, H; Zazgornik, J | 1 |
| Bonnaure-Mallet, M; Jolivet-Gougeon, A; Sixou, JL; Tamanai-Shacoori, Z | 1 |
| Akata, K; Fukuda, K; Ishimoto, H; Kato, K; Kawanami, T; Mukae, H; Naito, K; Noguchi, S; Taniguchi, H; Yamasaki, K; Yatera, K | 1 |
2 review(s) available for cilastatin and clindamycin
| Article | Year |
|---|---|
Therapy of mixed anaerobic-aerobic infections. Lessons from studies of intra-abdominal sepsis.
Topics: Abdomen; Abscess; Bacteria, Anaerobic; Bacterial Infections; Bacteroides; Cilastatin; Clindamycin; Cyclopropanes; Drug Combinations; Gentamicins; Humans; Imipenem; Thienamycins | 1985 |
Antimicrobial treatment of Capnocytophaga infections.
Topics: Animals; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Capnocytophaga; Cilastatin; Clindamycin; Endocarditis, Bacterial; Gram-Negative Bacterial Infections; Humans; Imipenem; Immunocompromised Host; Microbial Sensitivity Tests | 2007 |
11 trial(s) available for cilastatin and clindamycin
| Article | Year |
|---|---|
Antimicrobial management of postoperative infections in abdominal surgery: single or combination regimen?
Topics: Abdomen; Amoxicillin; Anti-Infective Agents; Bacterial Infections; Cilastatin; Clindamycin; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Middle Aged; Postoperative Complications; Prospective Studies; Randomized Controlled Trials as Topic; Surgical Wound Infection | 1990 |
Results of a multicenter trial comparing imipenem/cilastatin to tobramycin/clindamycin for intra-abdominal infections.
Topics: Abscess; Adult; Aged; Anti-Bacterial Agents; Cilastatin; Cilastatin, Imipenem Drug Combination; Clindamycin; Drug Combinations; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Middle Aged; Peritonitis; Prospective Studies; Severity of Illness Index; Tobramycin | 1990 |
Imipenem/cilastatin versus gentamicin/clindamycin: a cost effectiveness study.
Topics: Cilastatin; Clindamycin; Clinical Trials as Topic; Cost-Benefit Analysis; Cyclopropanes; Drug Combinations; Drug Therapy, Combination; Gentamicins; Humans; Imipenem; Random Allocation; Thienamycins | 1986 |
Randomized trial of imipenem-cilastatin versus gentamicin plus clindamycin in the treatment of polymicrobial infections.
Topics: Adult; Aged; Bacteria; Bacterial Infections; Cilastatin; Cilastatin, Imipenem Drug Combination; Clindamycin; Drug Combinations; Drug Evaluation; Drug Therapy, Combination; Female; Gentamicins; Humans; Imipenem; Male; Middle Aged; Random Allocation | 1988 |
Prospective study comparing imipenem-cilastatin with clindamycin and gentamicin for the treatment of serious surgical infections.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteria, Aerobic; Bacteria, Anaerobic; Bacterial Infections; Cilastatin; Cilastatin, Imipenem Drug Combination; Clindamycin; Clinical Trials as Topic; Cyclopropanes; Drug Combinations; Drug Therapy, Combination; Female; Gentamicins; Humans; Imipenem; Male; Middle Aged; Prospective Studies; Random Allocation; Thienamycins | 1988 |
Imipenem/cilastatin versus aminoglycoside plus amoxicillin plus clindamycin in the treatment of serious postoperative infections.
Topics: Adult; Aminoglycosides; Amoxicillin; Anti-Bacterial Agents; Bacterial Infections; Cilastatin; Cilastatin, Imipenem Drug Combination; Clindamycin; Clinical Trials as Topic; Cyclopropanes; Drug Combinations; Drug Therapy, Combination; Humans; Imipenem; Postoperative Complications; Prospective Studies; Random Allocation; Thienamycins | 1987 |
Randomized trial of imipenem/cilastatin versus gentamicin and clindamycin in mixed flora infections.
Topics: Adult; Aged; Bacterial Infections; Cilastatin; Clindamycin; Clinical Trials as Topic; Creatinine; Cyclopropanes; Drug Combinations; Female; Gentamicins; Humans; Imipenem; Male; Middle Aged; Random Allocation; Seizures; Thienamycins | 1985 |
Imipenem/cilastatin versus gentamicin/clindamycin for treatment of serious bacterial infections. Report from a Scandinavian Study Group.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; Cilastatin; Clindamycin; Clinical Trials as Topic; Cyclopropanes; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Gentamicins; Humans; Imipenem; Male; Middle Aged; Random Allocation; Thienamycins | 1984 |
Randomized comparative trial of imipenem/cilastatin versus aminoglycoside plus amoxycillin plus clindamycin in the treatment of severe intra- and post-operative infections.
Topics: Aminoglycosides; Amoxicillin; Anti-Bacterial Agents; Bacterial Infections; Cilastatin; Cilastatin, Imipenem Drug Combination; Clindamycin; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Female; Humans; Imipenem; Intraoperative Complications; Male; Middle Aged; Postoperative Complications; Prospective Studies | 1993 |
Comparison of imipenem/cilastatin with the combination of aztreonam and clindamycin in the treatment of intra-abdominal infections.
Topics: Abdomen; Adolescent; Adult; Aged; Aged, 80 and over; Aztreonam; Bacterial Infections; Cilastatin; Cilastatin, Imipenem Drug Combination; Clindamycin; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Middle Aged; Premedication; Prospective Studies; Surgical Wound Infection; Treatment Failure | 1993 |
Impact an anatomical site on bacteriological and clinical outcome in the management of intra-abdominal infections.
Topics: Adult; Aged; Anti-Bacterial Agents; Appendicitis; Bacterial Infections; Bacteriological Techniques; Cause of Death; Cilastatin; Clindamycin; Combined Modality Therapy; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Humans; Imipenem; Male; Meropenem; Middle Aged; Peritonitis; Risk Factors; Survival Rate; Thienamycins; Tobramycin; Treatment Outcome | 1998 |
11 other study(ies) available for cilastatin and clindamycin
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Fatal abdominal thorotrast granuloma.
Topics: Abdominal Neoplasms; Aged; Blood Chemical Analysis; Blood Transfusion; Cilastatin; Clindamycin; Granuloma; Humans; Imipenem; Male; Parenteral Nutrition, Total; Rectum; Thorium Dioxide; Thrombophlebitis; Ureteral Obstruction; Urinary Bladder | 1992 |
Comparison of the efficacy of three different treatments with imipenem versus the classical clindamycin plus tobramycin in experimental peritonitis.
Topics: Abscess; Animals; Ascitic Fluid; Cilastatin; Clindamycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Imipenem; Peritonitis; Rats; Rats, Inbred Strains; Tobramycin | 1991 |
Effects of antimicrobial prophylaxis on colonization resistance.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Aztreonam; Bacteria; Cilastatin; Cilastatin, Imipenem Drug Combination; Clindamycin; Colon; Cyclopropanes; Drug Combinations; Female; Humans; Imipenem; Male; Middle Aged; Premedication; Thienamycins | 1988 |
Imipenem therapy for perforated and gangrenous appendicitis.
Topics: Adult; Aged; Appendectomy; Appendicitis; Ascitic Fluid; Cilastatin; Clindamycin; Cyclopropanes; Drug Resistance, Microbial; Drug Therapy, Combination; Fever; Gangrene; Gentamicins; Humans; Imipenem; Intestinal Perforation; Length of Stay; Middle Aged; Rupture, Spontaneous; Thienamycins | 1986 |
[Case of streptococcal toxic shock-like syndrome].
Topics: Aged; Anti-Bacterial Agents; Cilastatin; Cilastatin, Imipenem Drug Combination; Clindamycin; Drug Combinations; Drug Therapy, Combination; Female; Hemofiltration; Humans; Imipenem; Shock, Septic; Streptococcal Infections; Streptococcus pyogenes | 1997 |
Cost analysis of imipenem-cilastatin versus clindamycin with tobramycin in the treatment of acute intra-abdominal infection.
Topics: Abdomen; Cilastatin; Clindamycin; Costs and Cost Analysis; Drug Combinations; Humans; Imipenem; Infections; Regression Analysis; Retrospective Studies; Tobramycin | 1993 |
Lung abscess (6 cm) of unexplained origin in a 36-year-old woman.
Topics: Adult; Arthritis, Reactive; Cilastatin; Cilastatin, Imipenem Drug Combination; Clindamycin; Diagnosis, Differential; Drug Combinations; Drug Therapy, Combination; Female; Humans; Imipenem; Infusions, Intravenous; Lung Abscess; Tomography, X-Ray Computed; Treatment Outcome | 2002 |
Successful Additional Corticosteroid Treatment in a Patient with Mycoplasma pneumoniae Pneumonia in whom a Monobacterial Infection was Confirmed by a Molecular Method Using Bronchoalveolar Lavage Fluid.
Topics: Adrenal Cortex Hormones; Adult; Anti-Bacterial Agents; Bronchoalveolar Lavage Fluid; Cilastatin; Cilastatin, Imipenem Drug Combination; Clindamycin; Disease Progression; Drug Combinations; Drug Resistance, Bacterial; Female; Fluoroquinolones; Humans; Imipenem; Minocycline; Mycoplasma pneumoniae; Oxazines; Pneumonia, Mycoplasma; Radiography, Thoracic; RNA, Ribosomal, 16S; Treatment Outcome | 2016 |